Table 2.
Average absorbed dose estimates for all ten subjects
| Target organ | Mean (mSv/MBq) | SD |
|---|---|---|
| Adrenals | 1.4E-02 | 3.0E-03 |
| Brain | 1.2E-02 | 2.1E-03 |
| Breasts | 8.8E-03 | 1.1E-03 |
| Gallbladder wall | 5.5E-02 | 3.5E-02 |
| LLI wall | 1.7E-02 | 2.5E-03 |
| Small intestine | 1.5E-02 | 2.2E-03 |
| Stomach wall | 1.3E-02 | 1.4E-03 |
| ULI wall | 1.5E-02 | 1.9E-03 |
| Heart wall | 2.2E-02 | 2.9E-03 |
| Kidneys | 2.5E-02 | 3.8E-03 |
| Liver | 2.3E-02 | 2.9E-03 |
| Lungs | 1.7E-02 | 2.6E-03 |
| Muscle | 1.2E-02 | 2.2E-03 |
| Ovaries | 1.7E-02 | 2.5E-03 |
| Pancreas | 1.4E-02 | 1.9E-03 |
| Red marrow | 2.2E-02 | 3.2E-02 |
| Osteogenic cells | 2.1E-02 | 1.8E-02 |
| Skin | 8.0E-03 | 9.0E-04 |
| Spleen | 1.2E-02 | 1.5E-03 |
| Testes | 1.3E-02 | 1.0E-03 |
| Thymus | 1.1E-02 | 1.3E-03 |
| Thyroid | 1.1E-02 | 1.3E-03 |
| Urinary bladder wall | 1.7E-01 | 1.4E-03 |
| Uterus | 2.3E-02 | 1.9E-03 |
| Total body | 1.4E-02 | 2.3E-03 |
| EDE | 2.9E-02 | 5.6E-03 |
| ED | 2.3E-02 | 5.3E-03 |
LLI lower large intestine, ULI upper large intestine